Catalyst Wire Dossier Catalyst Wire Dossier

GD2-targeted autologous CAR T cells

CAR T cells targeting GD2 · University of North Carolina Lineberger Comprehensive Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GD2-targeted autologous CAR T cells, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]

See pricing